Year |
Citation |
Score |
2024 |
Barbehenn A, Shi L, Shao J, Hoh R, Hartig HM, Pae V, Sarvadhavabhatla S, Donaire S, Sheikhzadeh C, Milush J, Laird GM, Mathias M, Ritter K, Peluso MJ, Martin J, et al. Rapid biphasic decay of intact and defective HIV DNA reservoir during acute treated HIV disease. Nature Communications. 15: 9966. PMID 39557853 DOI: 10.1038/s41467-024-54116-1 |
0.317 |
|
2024 |
Korolkova A, Ndukwe SO, Dee L, Deeks SG, Peluso MJ, Hoh R, Rodriguez A, Sugarman J, Rodriguez Garcia L, Dubé K, Sauceda JA. Recall and Appraisal of the Risks, Benefits, and Objectives of Interrupting HIV Treatment in an HIV Cure-Related Study. Aids and Behavior. PMID 39287733 DOI: 10.1007/s10461-024-04485-x |
0.304 |
|
2024 |
Barbehenn A, Shi L, Shao J, Hoh R, Hartig HM, Pae V, Sarvadhavabhatla S, Donaire S, Sheikhzadeh C, Milush J, Laird GM, Mathias M, Ritter K, Peluso M, Martin J, et al. Rapid Biphasic Decay of Intact and Defective HIV DNA Reservoir During Acute Treated HIV Disease. Medrxiv : the Preprint Server For Health Sciences. PMID 38585951 DOI: 10.1101/2024.03.27.24304867 |
0.309 |
|
2024 |
Reeves DB, Rigau DN, Romero A, Zhang H, Simonetti FR, Varriale J, Hoh R, Zhang L, Smith KN, Montaner LJ, Rubin LH, Gange SJ, Roan NR, Tien PC, Margolick JB, ... Peluso MJ, et al. Mild HIV-specific selective forces overlaying natural CD4+ T cell dynamics explain the clonality and decay dynamics of HIV reservoir cells. Medrxiv : the Preprint Server For Health Sciences. PMID 38405967 DOI: 10.1101/2024.02.13.24302704 |
0.303 |
|
2023 |
Marquez NG, Jamal A, Johnston R, Richter EI, Gorbach PM, Vannorsdall TD, Rubin LH, Jennings CL, Landay AL, Peluso MJ, Antar AAR. Characterizing Symptoms and Identifying Biomarkers of Long COVID in People with and without HIV: Protocol for a Remotely-Conducted Prospective Observational Cohort Study. Jmir Research Protocols. PMID 37104709 DOI: 10.2196/47079 |
0.306 |
|
2022 |
Peluso MJ, Spinelli MA, Deveau TM, Forman CA, Munter SE, Mathur S, Tang AF, Lu S, Goldberg SA, Arreguin MI, Hoh R, Tai V, Chen JY, Martinez EO, Yee BC, et al. Post-acute sequelae and adaptive immune responses in people living with HIV recovering from SARS-COV-2 infection. Aids (London, England). PMID 35866847 DOI: 10.1097/QAD.0000000000003338 |
0.329 |
|
2021 |
Peluso MJ, Hellmuth J, Chow FC. Central Nervous System Effects of COVID-19 in People with HIV Infection. Current Hiv/Aids Reports. 18: 538-548. PMID 34843065 DOI: 10.1007/s11904-021-00582-x |
0.341 |
|
2021 |
Claytor JD, Viramontes O, Conner S, Wen KW, Beck K, Chin-Hong PV, Henrich TJ, Peluso MJ. TNF-alpha inhibition in the setting of undiagnosed HIV infection: a call for enhanced screening guidelines. Aids (London, England). PMID 34115645 DOI: 10.1097/QAD.0000000000002985 |
0.322 |
|
2021 |
Spinelli MA, Lynch KL, Yun C, Glidden DV, Peluso MJ, Henrich TJ, Gandhi M, Brown LB. SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study. The Lancet. Hiv. PMID 33933189 DOI: 10.1016/S2352-3018(21)00072-2 |
0.308 |
|
2021 |
Dubé K, Kanazawa J, Dee L, Taylor J, Campbell DM, Brown B, Johnson MO, Saberi P, Sauceda JA, Sugarman J, Peluso MJ. Ethical and practical considerations for mitigating risks to sexual partners during analytical treatment interruptions in HIV cure-related research. Hiv Research & Clinical Practice. 1-17. PMID 33757411 DOI: 10.1080/25787489.2021.1902116 |
0.31 |
|
2020 |
Peluso MJ, Bakkour S, Busch MP, Deeks SG, Henrich TJ. A High Percentage of People with HIV on Antiretroviral Therapy Experience Detectable Low-Level Plasma HIV-1 RNA Following COVID-19. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 33211091 DOI: 10.1093/cid/ciaa1754 |
0.317 |
|
2020 |
Jiang C, Lian X, Gao C, Sun X, Einkauf KB, Chevalier JM, Chen SMY, Hua S, Rhee B, Chang K, Blackmer JE, Osborn M, Peluso MJ, Hoh R, Somsouk M, et al. Distinct viral reservoirs in individuals with spontaneous control of HIV-1. Nature. PMID 32848246 DOI: 10.1038/S41586-020-2651-8 |
0.4 |
|
2020 |
Peluso MJ, Dee L, Shao S, Taylor J, Campbell D, Collins S, Gandhi M, Johnston R, Deeks SG, Sauceda JA, Dubé K. Operationalizing HIV cure-related trials with analytic treatment interruptions during the SARS-CoV-2 pandemic: A collaborative approach. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32841311 DOI: 10.1093/Cid/Ciaa1260 |
0.419 |
|
2020 |
Ho HE, Peluso MJ, Margus C, Matias Lopes JP, He C, Gaisa MM, Osorio G, Aberg JA, Mullen MP. Clinical outcomes and immunologic characteristics of Covid-19 in people with HIV. The Journal of Infectious Diseases. PMID 32601704 DOI: 10.1093/Infdis/Jiaa380 |
0.369 |
|
2020 |
Jilg N, Garcia-Broncano P, Peluso M, Segal FP, Bosch RJ, Roberts-Toler C, Chen SMY, Van Dam CN, Keefer MC, Kuritzkes DR, Landay AL, Deeks S, Yu XG, Sax PE, Li JZ, et al. Hiv Controllers Maintain Viral Suppression Despite Waning T-Cell Responses On Art. The Journal of Infectious Diseases. PMID 32496516 DOI: 10.1093/Infdis/Jiaa294 |
0.404 |
|
2020 |
Ward LM, Peluso MJ, Budak JZ, Elicker BM, Chin-Hong PV, Lampiris H, Mulliken JS. Opportunistic coinfection with and associated with idelalisib treatment in a patient with chronic lymphocytic leukaemia. Bmj Case Reports. 13. PMID 32354764 DOI: 10.1136/Bcr-2019-234113 |
0.311 |
|
2020 |
Peluso MJ, Chen J, Munter S, Reed A, Teraoka J, Eshun-Wilson I, Henrich TJ, Chin-Hong PV. Outcomes of immunomodulatory and biologic therapy in people living with HIV: a report from two academic hospitals. Aids (London, England). PMID 32310901 DOI: 10.1097/Qad.0000000000002549 |
0.395 |
|
2020 |
Peluso MJ, Thanh C, Prator CA, Hogan LE, Arechiga VM, Stephenson S, Norris PJ, Di Germanio C, Fuchs D, Zetterberg H, Deeks SG, Gisslén M, Price RW, Henrich TJ. Cerebrospinal fluid soluble CD30 elevation despite suppressive antiretroviral therapy in individuals living with HIV-1. Journal of Virus Eradication. 6: 19-26. PMID 32175087 DOI: 10.1016/S2055-6640(20)30006-6 |
0.43 |
|
2020 |
Peluso MJ, Bacchetti P, Ritter KD, Beg SA, Lai J, Martin JN, Hunt PW, Henrich TJ, Siliciano JD, Siliciano RF, Laird GM, Deeks SG. Differential decay of intact and defective proviral DNA in HIV-1-infected individuals on suppressive antiretroviral therapy. Jci Insight. PMID 32045386 DOI: 10.1016/S2055-6640(20)30130-8 |
0.417 |
|
2020 |
Peluso MJ, Colby DJ, Pinyakorn S, Ubolyam S, Intasan J, Trichavaroj R, Chomchey N, Prueksakaew P, Slike BM, Krebs SJ, Jian N, Robb ML, Phanuphak P, Phanuphak N, Spudich S, et al. Liver function test abnormalities in a longitudinal cohort of Thai individuals treated since acute HIV infection. Journal of the International Aids Society. 23: e25444. PMID 31953919 DOI: 10.1002/Jia2.25444 |
0.617 |
|
2020 |
Peluso MJ, Dee L, Campbell D, Taylor J, Hoh R, Rutishauser RL, Sauceda J, Deeks SG, Dubé K. A collaborative, multidisciplinary approach to HIV transmission risk mitigation during analytic treatment interruption Journal of Virus Eradication. 6: 34-37. DOI: 10.1016/S2055-6640(20)30009-1 |
0.392 |
|
2019 |
Prator CA, Thanh C, Kumar S, Pan T, Peluso MJ, Bosch R, Jones N, Milush JM, Bakkour S, Stone M, Busch MP, Deeks SG, Hunt PW, Henrich TJ. Circulating CD30+ CD4+ T Cells Increase Prior to HIV Rebound Following Analytical Antiretroviral Treatment Interruption. The Journal of Infectious Diseases. PMID 31677350 DOI: 10.1093/Infdis/Jiz572 |
0.382 |
|
2019 |
Peluso MJ, Deeks SG, McCune JM. HIV "cure": A shot in the arm? Ebiomedicine. PMID 30982768 DOI: 10.1016/J.Ebiom.2019.04.011 |
0.425 |
|
2019 |
Kim SJ, Peluso MJ, Wang Y, Bikle D, Shoback D, Kim S. Rapid onset of hypercalcemia from high-grade lymphoma in the setting of HIV-related immune reconstitution inflammatory syndrome. Bone Reports. 10: 100194. PMID 30627599 DOI: 10.1016/J.Bonr.2018.100194 |
0.413 |
|
2019 |
Peluso MJ, Eshun-Wilson I, Henrich TJ, Chin-Hong P. 324. Outcomes of Immunomodulatory and Biologic Therapy in People Living with HIV: A Report from Two Academic Hospitals Open Forum Infectious Diseases. 6. DOI: 10.1093/Ofid/Ofz360.397 |
0.38 |
|
2019 |
Peluso M, Burbelo P, Kumar S, Munter S, Hoh R, Lee S, Hunt P, Rutishauser R, Henrich T, Deeks S. Characterising ‘exceptional’ control among HIV elite controllers Journal of Virus Eradication. 5: 31. DOI: 10.1016/S2055-6640(20)30153-9 |
0.38 |
|
2016 |
Peluso MJ, Valcour V, Phanuphak N, Ananworanich J, Fletcsher JL, Chalermchai T, Krebs SJ, Robb ML, Hellmuth J, Gisslén M, Zetterberg H, Spudich S. Immediate initiation of cART is associated with lower levels of cerebrospinal fluid YKL-40, a marker of microglial activation, in HIV-1 infection. Aids (London, England). PMID 27819802 DOI: 10.1097/Qad.0000000000001314 |
0.608 |
|
2015 |
Peluso MJ, Valcour V, Ananworanich J, Sithinamsuwan P, Chalermchai T, Fletcher JL, Lerdlum S, Chomchey N, Slike B, Sailasuta N, Gisslén M, Zetterberg H, Spudich S. Absence of Cerebrospinal Fluid Signs of Neuronal Injury Before and After Immediate Antiretroviral Therapy in Acute HIV Infection. The Journal of Infectious Diseases. PMID 25995196 DOI: 10.1093/Infdis/Jiv296 |
0.588 |
|
2014 |
Peluso MJ, Spudich S. Treatment of HIV in the CNS: effects of antiretroviral therapy and the promise of non-antiretroviral therapeutics. Current Hiv/Aids Reports. 11: 353-62. PMID 25063356 DOI: 10.1007/S11904-014-0223-Y |
0.621 |
|
2013 |
Peluso MJ, Meyerhoff DJ, Price RW, Peterson J, Lee E, Young AC, Walter R, Fuchs D, Brew BJ, Cinque P, Robertson K, Hagberg L, Zetterberg H, Gisslén M, Spudich S. Cerebrospinal fluid and neuroimaging biomarker abnormalities suggest early neurological injury in a subset of individuals during primary HIV infection. The Journal of Infectious Diseases. 207: 1703-12. PMID 23460748 DOI: 10.1093/Infdis/Jit088 |
0.605 |
|
2012 |
Peluso MJ, Ferretti F, Peterson J, Lee E, Fuchs D, Boschini A, Gisslén M, Angoff N, Price RW, Cinque P, Spudich S. Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load. Aids (London, England). 26: 1765-74. PMID 22614889 DOI: 10.1097/Qad.0B013E328355E6B2 |
0.588 |
|
Show low-probability matches. |